ClinicalTrials.gg
CompletedNCT06960811ASPAICUpdated Aug 6, 2025

Epileptic Psychoses and Their Link With Ictal Emotions and Consciousness

An observational study in Epilepsy With Partial Onset Seizures With or Without Secondary Generalization, Psychoses and Epilepsy, Generalized, sponsored by Central Hospital, Nancy, France. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-06.

Sponsored by Central Hospital, Nancy, France · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
117
Ages
18 Years and older
Sex
All
01

Study summary

Background :

Psychiatric comorbidities are common in epilepsy, affecting 50 to 70% of patients, especially when the epilepsy is focal and drug-resistant. Among these comorbidities, psychotic disorders (involving hallucinations and delusions) affect 8% of patients - that is, eight times more frequently than in the general population. Currently, the links between epilepsy and psychotic disorders are poorly understood and often overlooked by physicians, which impacts the mental health care of patients with epilepsy and leads to underdiagnosis.

The aim of this research is to determine whether there are differences in epileptic symptoms between patients with a psychotic comorbidity and those without.

Study design :

The main objective of this research is to better understand whether certain emotional epileptic symptoms are associated with a higher risk of developing psychotic symptoms.

The secondary objectives of this study are to investigate whether the level of consciousness during seizures is associated with a higher risk of developing psychotic symptoms.

To meet these objectives, the study will include patients who (1) have epilepsy, (2) were hospitalized in the video-EEG unit of the Neurology Department at Central Hospital for seizure recording, and (3) underwent a psychiatric evaluation in the context of epilepsy between January 1, 2016, and April 1, 2025.

The study will take place at the University Hospital Center (CHRU) of Nancy, in the Neurology Department, within the video-EEG unit led by Professor Louis Maillard. The research will involve comparing epileptic symptoms between the group of patients without psychosis and the group of patients with psychosis.

Data collection will cover the five days of video-EEG hospitalization, along with information from the psychiatric evaluation, for a total duration of approximately one week per year.

Information for participants:

As part of the routine medical care, data is collected in medical records to ensure appropriate follow-up. For the purposes of this research, data from the medical record will be collected.

No identifying information (such as name, initials, full date of birth, address, or social security number) will be collected.

No additional visits or examinations will be required. Patients will not be contacted or asked to provide any new information.

02

Conditions studied

  • Epilepsy With Partial Onset Seizures With or Without Secondary Generalization
  • Psychoses
  • Epilepsy, Generalized

Keywords

  • psychoses of epilepsy
  • postictal psychosis
  • interictal psychosis
  • epilepsy
  • clinical research
03

In context

Psychotic Disorders

1,587 studies on the registry are indexed under Psychotic Disorders; 281 are open to participants now.

This study's enrollment of 117 is close to the median of 123 across 221 observational studies indexed under Psychotic Disorders.

Browse Psychotic Disorders studies →

Lead sponsor

Central Hospital, Nancy, France is the lead sponsor of 798 studies on the registry; 186 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with a certain diagnosis of epilepsy, based on a video-EEG monitoring, hospitalized in tertiary center for epilepsy care, and who have a psychiatric evaluation specialized in patients with epilepsy.

There are limited exclusion criteria to ensure the best representation of patients with epilepsy

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with a confirmed diagnosis of epilepsy
  • Patients hospitalized for at least 5 days for a video-EEG recording
  • Patients with a psychiatric evaluation, conducted between 01/01/2016 and 04/01/2025.
  • Adult patients able to express their opposition to the use of their data.

Exclusion criteria

Exclusion Criteria:

  • Absence of seizure recorded during the video-EEG
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
117 participants (actual)
Patient registry
No

Groups and cohorts

  • PEP +

    Patients diagnosed with epilepsy based on video-EEG recording of seizures and with a psychotic comorbidity according to a standardized psychiatric assessment specialized in Epi-Psy

  • PEP -

    Patients diagnosed with epilepsy based on video-EEG recording of seizures and without psychotic comorbidity according to a standardized psychiatric assessment specialized in Epi-Psy

06

What researchers measure

Primary outcomes

  1. Ictal emotions

    Clinician-assessment of ictal affective symptomatology (facial, verbal, and motor expression), based on a the visualization of an usual seizure recorded in video-EEG.

    Time frame: From april 2025 to may 2025

Secondary outcomes

  1. Ictal consciousness

    Clinician-rating of the Consciousness Seizure Scale (CSS) validated for the assessment of level of consciousness during a seizure. Scores on the CSS range from 0 to 9, which can be interpreted as follows * 0 or 1 meaning a profound alteration of consciousness during seizure * 2 to 5 meaning an intermediate alteration of consciousness during seizure * 6 and more meaning a relatively preserved consciousness during seizure

    Time frame: From april 2025 to may 2025

  2. Ictal dysautonomy

    Measures of neurovegetatives signs during seizures based on ictal EKG, nurse examination (palor, ...)

    Time frame: From april 2025 to may 2025

  3. Type of aura

    Assessment of the type of aura based on the patients description of their seizure and on the video-EEG recording at the beginning of the seizure

    Time frame: From april 2025 to may 2025

07

Study locations

1 site
  • Center Hospital of Nancy
    Nancy, Lorraine 54000, France
08

References and documents

Publications

  • Tarrada A, Aron O, Vignal JP, Ertan D, Maillard L, Hingray C. Anticipatory anxiety of seizures is associated with ictal emotional distress and amygdala onset seizures. Epilepsia. 2022 May;63(5):1130-1140. doi: 10.1111/epi.17215. Epub 2022 Mar 20. PubMed 35263805 ↗
  • Tarrada A, Hingray C, Sachdev P, Le Thien MA, Kanemoto K, de Toffol B. Epileptic psychoses are underrecognized by French neurologists and psychiatrists. Epilepsy Behav. 2019 Nov;100(Pt A):106528. doi: 10.1016/j.yebeh.2019.106528. Epub 2019 Oct 24. PubMed 31654941 ↗
  • Hesdorffer DC, Ishihara L, Mynepalli L, Webb DJ, Weil J, Hauser WA. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol. 2012 Aug;72(2):184-91. doi: 10.1002/ana.23601. Epub 2012 Aug 7. PubMed 22887468 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06960811
Responsible party
TARRADA Alexis (M.D., Central Hospital, Nancy, France) — Principal investigator
First posted
May 7, 2025
Start date
May 2, 2025
Primary completion
Aug 5, 2025
Completion
Aug 5, 2025
Last update
Aug 6, 2025

Study contacts

Coraline Hingray, MD, PhD
study director · Psychotherapeutic Center of Nancy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion